0000000000230876

AUTHOR

Yanzhi Hsu

showing 1 related works from this author

Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysis

2019

Sorafenibmedicine.medical_specialtyElevated alpha-fetoproteinbusiness.industryHematologymedicine.diseaseGastroenterologyRamucirumabInterval dataOncologyInternal medicineHepatocellular carcinomaMedicineIn patientProgression-free survivalbusinessExposure responsemedicine.drugAnnals of Oncology
researchProduct